gd-tex-malonato-platinum conjugate

**gd-tex-malonato-platinum conjugate** is a PEG-solubilized chemical conjugate consisting of a tumor-localizing gadolinium texaphyrin (Gd-Tex) core linked to a malonate-platinum moiety that acts as a platinum delivery vehicle[1][2][5]. The malonate group is designed analogously to carboplatin, releasing Pt(NH3)2 under physiological conditions—a process with a half-life of approximately 3 days at room temperature in phosphate-buffered saline[1][2]. Its antitumor mechanism is not definitively established but likely involves DNA crosslinking by released platinum (similar to carboplatin and cisplatin), oxidative stress induced by the texaphyrin ring, or both[1]. In preclinical studies, gd-tex-malonato-platinum conjugate demonstrated antiproliferative activity comparable to carboplatin in A549 human lung cancer and A2780 human ovarian cancer cell lines, and showed *superior activity to carboplatin in platinum-resistant ovarian cell lines*[1]. The conjugate is under research as a targeted chemotherapy agent, designed for improved solubility, tumor localization, and potentially enhanced efficacy against platinum-resistant cancers[1][2][5].

Other names

gadolinium texaphyrin-malonato-platinum conjugateGd-Tex-malonato-Pt conjugateGd-Tex-Pt conjugate